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The Histamine H4 Receptor Is Highly Expressed
on Plasmacytoid Dendritic Cells in Psoriasis
and Histamine Regulates Their Cytokine Production
and Migration
Maria Gschwandtner1,2, Susanne Mommert1, Brigitta Ko¨ther1, Thomas Werfel1 and Ralf Gutzmer1
Plasmacytoid dendritic cells (pDC) are present in inflammatory skin lesions, in particular, in psoriasis. In such
lesions, the inflammatory mediator histamine is also detected in high amounts. We therefore investigated a
possible interaction of pDC with histamine, especially via the most recently described histamine H4 receptor (H4R).
We detected the expression of the H4R on pDC in the blood and in lesional psoriasis skin. Interestingly, compared
with healthy controls and patients with atopic dermatitis, pDC from the blood of psoriasis patients expressed the
highest levels of the H4R, which was even more upregulated on stimulation with IFN-g and CpG. After activation of
the H2R and H4R on pDC, we observed downregulation of CpG-induced production of tumor necrosis factor a,
IFN-a, and CXCL8, but not of the chemokine CXCL10. Histamine-induced downregulation of cytokine production
was more pronounced in pDC derived from psoriasis patients. Furthermore, we observed F-actin polymerization
and active migration of pDC in response to H4R agonist stimulation. Taken together, our results indicate that the
H4R is highly expressed on pDC in psoriasis and influences cytokine production and migration of pDC. Therefore,
the H4R alone or in combination with the H2R might be a promising therapeutic target in psoriasis.
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INTRODUCTION
Various types of dendritic cells (DC) have an important role in
inflammatory skin diseases. Among them plasmacytoid
dendritic cell (pDC) which represent a rare dendritic cell
(DC) sub-population characterized by plasma cell-like
shape and the surface marker phenotype CD4þ , CD45RAþ ,
CD123þ (also known as IL-3Ra), BDCA-2þ , BDCA-4þ ,
ILT3þ , and CD11c, lineage (Colonna et al., 2004). In
contrast to other DC subtypes, pDC do not express the toll-
like receptors (TLR) 2–5 on their surface, but they express
TLR7 and TLR9 in their endosomal compartments (Hochrein
et al., 2002). In response to stimulation of these innate
receptors with single-stranded RNA and unmethylated CpG
oligodeoxynucleotides, pDC have the unique capacity to
produce massive amounts of type I interferons and other
proinflammatory cytokines, such as tumor necrosis factor
(TNF)-a, CXCL10, and CXCL8 (Hochrein et al., 2002; Ito
et al., 2004). pDCs are of particular importance in antiviral
immunity; however, by their cytokine production they can
influence immune responses in general, by modulating the
function of T cells, antigen-presenting cells and keratinocytes
(Colonna et al., 2004).
pDC typically reside in the peripheral blood and are
absent in healthy skin, but they were shown to infiltrate
lesions of inflammatory skin diseases, such as lupus
erythematosus, allergic contact dermatitis, atopic dermatitis,
and psoriasis (Wollenberg et al., 2002; Bangert et al., 2003;
Stary et al., 2005). Especially in psoriasis pDCs seem to be of
pathogenetic relevance as pDCs are recruited to the skin and
their activation results in high-level secretion of IFN-a. One
key factor activating pDC in psoriasis is LL37, an antimicro-
bial peptide abundant in psoriasis. LL37 was shown to be
involved in the conversion of self-DNA into danger signal,
which is recognized by pDC and thereby drives autoimmu-
nity in psoriasis (Lande et al., 2007). Moreover, it was shown
that psoriasis patients have increased serum levels of pDC-
derived cytokines correlating with the severity of psoriasis
(Arican et al., 2005). These findings provide good evidence
that pDCs are involved in the pathology of psoriasis;
however, the exact mechanism how pDC migrate to the
inflamed skin in psoriasis and how their function is regulated
in disease is not elucidated in detail yet.
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As histamine is also present in high amounts in lesions of
psoriasis (Krogstad et al., 1997) and therefore comes into
contact with pDC, we decided to investigate the functional
role of histamine on pDC. Histamine can bind to four
different seven-transmembrane histamine receptors (HxR),
which are signaling through coupled G-proteins and have
diverse functions in physiological and pathological pro-
cesses. The H1R, H2R, and H4R have a role as regulators of
immune responses, the H2R is involved in gastric acid
secretion and the H3R is important for neurotransmission.
Concerning the function of histamine on immune cells
several studies have been performed, showing that histamine
affects the migration behavior and mediator secretion of T
cells (Gutzmer et al., 2009), monocytes (Dijkstra et al., 2007),
eosinophils (Ling et al., 2004), and keratinocytes (Giustizieri
et al., 2004; Gschwandtner et al., 2008). Regarding the role
of histamine on pDC a previous study showed histamine-
mediated downregulation of TNF-a and IFN-a production
(Mazzoni et al., 2003), which was in part attributed to the
H2R. However, this study did not take into account the most
recently discovered H4R (Nakamura et al., 2000), which is of
particular importance in the regulation of immune cells
(Zampeli and Tiligada, 2009). Therefore, we hypothesized
that the H4R has a role in pDC biology and, hence, we
performed detailed analysis of the expression, regulation and
function of the H4R on pDC, especially in the context of the
inflammatory skin disease psoriasis.
RESULTS
High expression of the H4R on pDC in skin and blood
of psoriasis patients
The expression of the H4R and other histamine receptors on
isolated pDC from buffy coats was tested at the mRNA level
by LightCycler real-time PCR. Although we could regularly
detect mRNA for H1R, H2R, and H4R, but we could not detect
mRNA for the H3R on pDC (Figure 1).
To further evaluate H4R expression in situ, we per-
formed immunofluorescence staining in skin samples
from psoriasis patients, in which the infiltration of pDC
has been described previously (Wollenberg et al., 2002;
Nestle et al., 2005). As depicted in Figure 2, we detected
double-positive pDC expressing the H4R in the dermis of
psoriasis patients.
To analyze H4R expression on the protein level in blood
pDC, peripheral blood mononuclear cells (PBMCs) were
isolated from peripheral blood and pDCs were identified
by cell surface staining of CD123 and absence of lineage
staining (CD3, CD14, CD16, and CD19). Intracellular
staining of the gated pDC showed that pDC express the
H4R on the protein level (Figure 3a). We analyzed H4R
expression levels on pDC derived from individuals without
inflammatory skin diseases, patients with atopic dermatitis
and patients with psoriasis and observed significantly higher
H4R expression on pDC derived from patients with psoriasis
(Figure 3b).
Cytokine regulation of H4R expression
The regulation of H4R expression on pDC was investigated
after stimulation with the Th1-associated cytokine IFN-g, the
TLR9 ligand CpG, and the Th2 cytokine IL-13. We observed
significant upregulation of the H4R upon IFN-g and CpG
stimulation on pDC derived from psoriasis patients, whereas
IL-13 had no effect (Figure 3c). In pDC derived from patients
with atopic dermatitis and healthy control subjects, we did
not observe H4R regulation with any of the used cytokines
(Figure 3c).
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Figure 1. Plasmacytoid dendritic cells (pDC) isolated from buffy coats express the histamine receptors H1R, H2R, and H4R at the mRNA level.
Representative real-time PCR melting peaks and agarose gel bands of the PCR products of two independent experiments are depicted (continuous line, pDC;
dotted line, negative control without reverse transcription; line with boxes, H3R-transfected HEK cells as positive control for H3R amplification).
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; HxR, histamine receptor.
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Histamine mediates the downregulation of CpG-induced
TNF-a, IFN-a, and CXCL8 secretion, in particular, in pDC
derived from psoriasis patients
It has been described previously that pDCs are the principal
producers of IFN-a and that they also secrete high amounts
of TNF-a and of the chemokines CXCL8 and CXCL10
(Ito et al., 2004). We confirmed this finding in our study
and additionally show that stimulation of pDC with the
H4R-specific agonist 4-methylhistamine (4-MH) downregu-
lated the secretion of TNF-a, IFN-a, and CXCL8 into the
cell culture supernatant. In presence of the selective H4R
antagonist JNJ7777120, the H4R agonist-induced down-
regulation of cytokines was completely blocked, whereas
the histamine effect was only blocked partially (Figure 4a). As
pDC also express the H1R and H2R on mRNA level (Figure 1),
we tested in addition agonists at these receptors. Cytokine
secretion was not influenced by stimulation with the H1R
agonist 2-pyridylethylamine, but we observed downregu-
lation after stimulation with the H2R agonist amthamine
(Figure 4b). For TNF-a and IFN-a, the involvement of the H2R
was already shown previously by experiments using H2R
antagonists (Mazzoni et al., 2003), for CXCL8 this finding is
new. With none of the used histamine receptor agonists, we
did observe significant differences in the secretion of the
chemokine CXCL10 (Figure 4a and b).
Interestingly, in pDC derived from psoriasis patients
(expressing higher levels of the H4R as shown in Figure 3)
histamine-induced downregulation of cytokines was more
pronounced than in healthy controls (Figure 5). For IFN-a, we
observed a downregulation by 25% in healthy controls and
45% in psoriasis patients, for TNF-a 30% and 85% and for
CXCL8 15% and 75%, respectively. In psoriasis patients even
the secretion of CXCL10 was reduced by 45%, in contrast in
healthy controls no effect on CXCL10 was observed at all
(Figures 4 and 5).
H4R stimulation induced migration of pDC
The effect of H4R stimulation on the migration of pDC was
assessed by F-actin polymerization as readout for cytoskeleton
reorganization and by cell migration assays. The H4R agonist
4-MH and C3a as positive control (Gutzmer et al., 2006)
induced F-actin polymerization after short periods of
stimulation and pre-incubation with the H4R antagonist
JNJ7777120 blocked H4R agonist induced F-actin polymer-
ization (Figure 6a and b). In accordance with these findings,
we observed higher migration of pDC in response to the H4R
agonist and C3a in comparison to non-stimulated cells
(Figure 6c and d).
DISCUSSION
An increased number of mast cells is present in the upper
dermis and even in the epidermis of psoriasis patients
(Cox, 1977; Harvima et al., 2008) and the appearance of
degranulated mast cells is an early feature of developing
psoriasis lesions (Schubert and Christophers, 1985). Further-
more, the concentration of the most important mast cell
mediator histamine is increased in psoriasis lesions (Petersen
et al., 1998). Also pDCs are found early in lesional skin of
psoriasis patients (Wollenberg et al., 2002) and have an
important role in the pathology of this inflammatory skin
disease (Nielsen, 1991; Nestle et al., 2005). These findings
show that pDC and histamine come into contact in lesions
of psoriasis; nevertheless, the functional role of histamine on
pDC is not elucidated in detail yet. One previous study
was performed showing histamine-induced downregulation
of IFN-a and TNF-a secretion from pDC, an effect that was
mainly attributed to the H2R (Mazzoni et al., 2003).
However, as the most recently discovered H4R (Nakamura
et al., 2000) was not considered in this study, we aimed to
elucidate the expression, regulation, and functional role of
the H4R on pDC.
In the present study, we show for the first time that pDC,
isolated from peripheral blood and pDC in situ in psoriasis
lesions, express the H4R. When measuring H4R expression in
different patient groups we observed increased expression of
the H4R on pDC derived from patients with psoriasis,
whereas for atopic dermatitis no significant difference was
observed. Interestingly, the high level of H4R expression on
CD123: plasmacytoid DC Isotype controls
H4R H4R + CD123
5 μm
5 μm 5 μm
5 μm 5 μm
Figure 2. The H4R is expressed in situ on plasmacytoid dendritic cells in psoriasis skin. Immunofluorescence staining of skin from psoriasis patients with anti-
CD123 (a) and anti-H4R (b) shows colocalization of the H4R on CD123 positive cells in the dermis (c). One representative experiment of four is shown.
The location of the basement membrane is indicated by the white scattered line. Bar¼ 5 mm. HxR, histamine receptor.
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psoriasis pDC did further increase on stimulation with IFN-g
and CpG. IFN-g is a predominant cytokine found in lesions
and blood of psoriasis patients (Szabo et al., 1998; Arican
et al., 2005), where it can interact with pDC and upregulate
H4R expression. The regulation of the H4R on IFN-g
stimulation was also observed on other DC subtypes involved
in inflammatory skin diseases, such as inflammatory dendritic
epidermal cells (Dijkstra et al., 2008) and slanDC
(Gschwandtner et al., 2011). In the present study, we also
found upregulation of the H4R on stimulation with CpG,
which is a potent activator of pDC in general. In contrast, the
Th2-associated cytokine IL-13 did not have an effect on H4R
expression on psoriasis pDC. Interestingly, we did not
observe regulation of the H4R by the tested cytokines in
pDC derived from healthy controls or patients with atopic
dermatitis. Together with the per se higher H4R expression on
pDC from psoriasis patients, these findings are the first
showing disease-dependent regulation of histamine receptor
expression in psoriasis. The mechanisms underlying this
differential regulation of H4R expression in psoriasis still need
to be elucidated and will be subject to future studies. Of note,
recently the regulation of the H4R expression on the genetic
level was reported, e.g., polymorphisms in the HRH4 gene
were shown to be associated with high H4R expression in
atopic dermatitis (Yu et al., 2010b) and the HRH4 gene copy
number was significantly increased in patients with lupus
erythematosus (Yu et al., 2010a).
As our data shows that pDC in the blood as well as in the
inflamed skin express high levels of the H4R and are thereby
able to respond to histamine, which is released by basophils
in the circulation (Bochner, 2000) and by mast cells in the
dermis of psoriasis patients (Krogstad et al., 1997), we
continued to identify the functional relevance of the H4R
on pDC. Therefore, we investigated the secretion of the most
important pDC-derived cytokines and chemokines: IFN-a,
TNF-a, CXCL10 (IP-10), and CXCL8 (IL-8) (Hochrein et al.,
2002). After stimulation with histamine, binding to all four
histamine receptors or a H4R-specific agonist, we observed
decreased CpG-induced secretion of TNF-a, IFN-a, and
CXCL8, whereas for the chemokine CXCL10 no effect was
detected. By experiments using the H4R selective antagonist
JNJ7777120, we showed that the H4R agonist-induced
downregulation of cytokines could be completely blocked.
In contrast, the histamine-induced downregulation was only
partially blocked, indicating that also another histamine
receptor is involved. Indeed, a previous study showed H2R-
mediated downregulation of IFN-a and TNF-a secretion from
pDC (Mazzoni et al., 2003). In their study, Mazzoni et al.
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Figure 3. The H4R is highly expressed on blood plasmacytoid dendritic cells (pDC) derived from psoriasis and upregulated by IFN-c and CpG. (a) pDC in
peripheral blood mononuclear cells (PBMC) were identified by cell surface staining with CD123 and negative lineage staining (the percentage of pDC
in healthy controls was B1%, in atopic dermatitis (AD) 1.1%, and in psoriasis 0.6% of whole PBMC). Representative histograms of isotype staining and H4R
staining on healthy and psoriasis pDC are shown. Panel b depicts a summary of all performed experiments (individual values and median of 17 independent
experiments per group are shown). (c) PBMCs were stimulated for 48 hours with 20 ngml1 IFN-g, 10 mgml1 CpG, or 50 ngml1 IL-13 and H4R expression on
pDC was determined using flow cytometry. Box plots of seven independent experiments performed with pDC derived from patients with psoriasis, atopic
dermatitis, and healthy controls are shown (the relative expression levels of H4R were calculated as follows: specific staining times 100 divided by isotype
staining). HxR, histamine receptor. *Po0.05, **Po0.005.
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described histamine-induced downregulation of IFN-a with
varying magnitude depending on the TLR ligand used for
stimulation; however, the effect was more pronounced than
in our study. For TNF-a, the downregulation observed after
histamine stimulation was comparable to the experiments
performed by us. In their study, Mazzoni et al. showed only
partial blockade of histamine using the H2R selective
antagonist ranitidine and the tested H1R and H3R antagonists
were ineffective in blocking histamine-induced downregula-
tion of cytokine production. In the present study, we used
specific histamine receptor agonists to confirm, that the H1R
is not involved in the regulation of cytokine secretion from
pDC and to show that cytokine production is downregulated
to a similar extent by H2R and H4R agonists. These findings
indicate that both receptors have a central role in down-
regulating the proinflammatory cytokine production in pDC.
The combined action of the H2R and the H4R on cytokine
secretion was also observed previously in monocyte-derived
DC (Gutzmer et al., 2005).
The cytokines downregulated by histamine stimulation on
pDC—TNF-a, IFN-a and CXCL8—have a major role in the
pathology of psoriasis as they lead to the activation and
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infiltration of T cells, affect the Th1/Th2 balance in their
microenvironment and activate keratinocytes to produce
proinflammatory cytokines (Nestle et al., 2005; Fantuzzi
et al., 2008). Because of these widespread functions
the histamine-mediated downregulation of pDC-derived
cytokines influences the local cellular immune response in
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many ways. The important role of histamine in psoriasis is
supported by the finding that in pDC derived from patients
with psoriasis the downregulation of cytokines was more
pronounced than in pDC derived from healthy controls.
In psoriasis patients, we even detected downregulation of the
chemokine CXCL10, an effect that was not observed in
healthy controls. These findings indicate that pDC in psoriasis
do not only show increased expression of the H4R, but that
they also demonstrate a different functional response to
stimulation with histamine.
Another important function of pDC is migration, leading
to their initial recruitment to the inflamed skin and on their
activation and maturation to the mobilization to lymph
nodes. Although several mediators have been shown to be
involved in pDC migration, such as C3a and C5a (Gutzmer
et al., 2006), CXCR4 (Pablos et al., 1999), and ChemR23
(Vermi et al., 2005; Albanesi et al., 2009), the process of pDC
migration is not fully elucidated yet. In the present study, we
identify histamine as another chemotactic stimulus for pDC.
We observed F-actin polymerization and the active migration
of pDC in response to H4R stimulation. As histamine is
an early product in lesions of psoriasis it might be one of the
initial signals leading to the immigration of pDC. A recent
study investigating the migration of pDC to lymph nodes
reported a crucial role of histamine in pDC migration to the
lymph node following peptidoglycan injection (Dawicki
et al., 2010). This dependence seemed to be specific for
pDC, as the migration of CD11b DC did not rely on
histamine. The study showed that the H2R antagonist
ranitidine was only partially effective in blocking the
migration, whereas H1R antagonists were ineffective. H4R
antagonists were not investigated in this study, but because of
our findings one could assume that the H4R also has a role in
the migration to lymph nodes.
Taken together, our study provides good evidence that not
only, as previously described, the H2R but also the H4R
influences pDC migration and cytokine production. Together
with other studies describing anti-inflammatory properties of
the H4R on different antigen-presenting cell subsets (Gutzmer
et al., 2005; Dijkstra et al., 2008; Gschwandtner et al., 2010),
these findings indicate that histamine has an important role in
downregulating immune responses in the skin. H4R ligands,
alone or in combination with H2R ligands, might therefore
be of potential in the treatment of inflammatory skin diseases.
This might be true especially for psoriasis, as we could
demonstrate significantly higher basal H4R expression,
differential receptor regulation by cytokines and a more
pronounced response to stimulation of the H4R in psoriasis.
MATERIALS AND METHODS
Isolation and culture of PBMC and pDC
Peripheral blood samples were taken from patients with severe
extrinsic atopic dermatitis or psoriasis, patients without inflamma-
tory skin disease served as controls. Patients were diagnosed and
treated in our department; they did not receive systemic treatment
during a 2 weeks period before blood withdrawal. All participants
gave their written informed consent. PBMC were separated by
density centrifugation on lymphoprep (Fresenius Kabi Norge AS,
Oslo, Norway) and erythrocytes were removed by incubation with
Gey’s lysis buffer. For the isolation of pDC, buffy coats from
anonymous healthy donors were obtained from the local blood
bank. pDCs were isolated by negative magnetic selection using pDC
isolation kit from Miltenyi Biotech (Bergisch-Gladbach, Germany).
The isolated pDC had a purity of at least 90% based on expression of
CD123, BDCA-2, and HLA-DR, and lack of expression of CD3,
CD14, CD16, and CD19.
PBMC and pDC were cultured in Iscoves medium supple-
mented with 2mM L-glutamin, 100mgml1 penicillin/streptomycin,
1 non-essential amino acids, 0.05mgml1 gentamycin, and 6% v/v
fetal calf serum at 37 1C in a humidified atmosphere containing 5%
CO2. pDCs were stimulated with IL-3 (10 ngml1, Immunotools,
Friesoythe, Germany) to avoid apoptosis and to acquire an immature
pDC phenotype with upregulation of co-stimulatory molecules
(Grouard et al., 1997) for 48 hours before starting of experiments.
Messenger RNA isolation, reverse transcription, and
quantitative real-time PCR
Isolated pDCs were washed in phosphate-buffered saline (PBS) and
lysed for RNA isolation using the Mini RNA Isolation II kit (Zymo
Research, Orange, CA) and reverse transcription was performed with
the Quantitect reverse transcription kit (Qiagen, Hilden, Germany).
As control, complementary DNA of H3R-transfected HEK cells was
prepared analogously. Real-time quantitative PCR was performed
on a LightCycler (Roche Molecular Biochemicals, Mannheim,
Germany) using SYBR Green with Quantitect primer assays for
H1R (QT00199857), H2R (QT00210378), H3R (QT00210861), H4R
(QT00032326), and glyceraldehyde-3-phosphate dehydrogenase
(QT01192646) as housekeeping gene according to the manufac-
turer’s instructions (Qiagen). The following PCR settings were used:
an initial activation step of 15minutes at 95 1C with ramp 20 1C per
second was followed by three-step cycling (45 cycles): denaturation
15 seconds, 94 1C; annealing 20 seconds, 55 1C; extension 20 sec-
onds, 72 1C (all three with ramp 2 1C per second). Melting curve
analysis was performed from 60 to 90 1C with ramp 20 1C per
second. The amount of target genes relative to the reference
glyceraldehyde-3-phosphate dehydrogenase and the melting point
was analyzed using Relative Quantification software (Roche
Molecular Biochemicals). To visualize the amplification products
agrose gel electrophoresis was performed with 2% agarose (Roth,
Karlsruhe, Germany) in 1 Tris-Borat-EDTA buffer (Roth).
Immunofluorescence staining of the H4R and pDC
Paraffin embedded sections (5mm) from skin biopsies derived from
patients diagnosed with psoriasis were transferred to SuperFrost Plus
microscope slides (Menzel-Gla¨ser, Braunschweig, Germany). After
drying, the sections were deparaffinated and treated with antigen
unmasking solution (Vector Laboratories, Burlinghame, CA). After
washing, the sections were incubated in goat serum for 1 hour at
room temperature and then stained with anti-H4R (SantaCruz
Biotechnology, Santa Cruz, CA) or rabbit IgG overnight. The next
day the staining was continued with secondary antibody (biotiny-
lated goat anti-rabbit antibody, Vectastain ABC kit, alkaline
phosphatase rabbit; Vector Laboratories) for 1 hour at room
temperature and avidin-fluorescein (Vector Laboratories) for 5min-
utes at room temperature. Following this, the slides were stained
with anti-CD123 (BD Pharmingen, Heidelberg, Germany) overnight
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at 4 1C. The stained sections were covered with mounting medium
(Vectashield; Vector Laboratories) and coverslips. Fluorescence
images were obtained with a Zeiss Axiolab microscope with
AxioCam MRm, and images were acquired with the program
AxioVS40 (version 4.6.1.0; Carl Zeiss MicroImaging GmbH, Go¨ttin-
gen, Germany).
Flow cytometric analysis of H4R expression
The cells were washed twice in PBS and then incubated for 20minutes
in PBS-containing human IgG (FcgR-blocking buffer). The cell surface
was stained with CD123-PECy5 (BD Pharmingen) and lineage markers
(CD3-PE, CD14-PE, CD16-PE, and D19-PE) or the respective isotype
controls. Subsequently cells were fixed and permeabilized (Fixation/
Permeabilization Kit, eBioscience, San Diego, CA). Intracellular
staining was performed with H4R antibody recognizing amino acids
194–303 (SantaCruz Biotechnology) or polyclonal rabbit isotype control
(R&D Systems, Wiesbaden, Germany), followed by labeling with goat
anti-rabbit-FITC (Beckman Coulter, Krefeld, Germany). CD123, linage,
and H4R positivity of the cells were assessed by flow cytometry (FACS
Calibur; Becton Dickinson, Heidelberg, Germany).
For the measurement of H4R expression in response to cytokine
stimulation the cells were incubated for 48 hours with 20 ngml1
IFN-g (R&D Systems), 50 ngml1 IL-13 (Peprotech, Hamburg,
Germany) or 10 mgml1 CpG oligonucleotide ODN2216 (50-ggGGG
ACGATCGTCgggggG-30, TIB MOLBIOL, Berlin, Germany).
ELISA
1 105 pDCs per well were cultured in IL-3-containing medium
(10 ngml1) for 48 hours and were either not stimulated or
stimulated with 10 mM histamine (Alk-Scherax, Wedel, Germany),
the H1R agonist 2-pyridylethylamine, the H2R agonist amthamine or
the H4R agonist 4-MH (all from Tocris Bioscience, Bristol, UK) and
activated with 10 mgml1 CpG ODN2216 (TIB MOLBIOL) for
24 hours. For blocking experiments the cells were treated with the
H4R antagonist JNJ7777120 (Sigma-Aldrich, Deisenhofen, Germany)
30minutes before stimulation with receptor agonists. Cell-free
supernatants were collected after 24 hours and the cytokine content
was analyzed using commercially available ELISA according to the
manufacturer’s instructions: IFN-a (IBL, Hamburg, Germany), TNF-a
(eBioscience), CXCL8, and CXCL10 (R&D Systems).
Assessment of F-actin polymerization
Nitrobenzoxadiazole-phallacidin (Invitrogen, Darmstadt, Germany)
staining of pDC was carried out as described previously (Gutzmer
et al., 2006). Briefly, cells were resuspended at a concentration of
1 106 cells per ml in PBS lacking Ca2þ and were stimulated with
the H4R agonist 4-MH (10 mM, Tocris Bioscience) or C3a as positive
control (1mgml1, Calbiochem, Darmstadt, Germany) for short
periods of time (0, 15, 30, and 60 seconds) at room temperature. For
blocking experiments cells were incubated with the H4R antagonist
JNJ7777120 (Sigma-Aldrich) 15minutes before addition of 4-MH.
Following stimulation, cells were fixed using 3.7% formaldehyde for
60minutes. Lysophosphatidylcholine (20 mgml1, Sigma-Aldrich)
and 3.7 107 M nitrobenzoxadiazole-phallacidin were added to
the sample and incubated for a period of 60minutes in the dark.
Nitrobenzoxadiazole-phallacidin-stained cells were analyzed on a
Becton Dickinson FACScalibur with a linear fluorescence channel
(FL-1), in which the fluorescence is proportional to F-actin content.
Relative F-actin content was normalized to the mean channel
fluorescence time as zero.
Chemotaxis assay
The chemotactic activity of pDC was determined using the micro
chamber technique ChemoTx System (Neuro Probe, Gaithersburg,
MD). Isolated pDC precursors were cultured for 48 hours in medium
containing IL-3 (10 ngml1). Then, 1 106 pDC per ml were labeled
in PBS with 5 mgml1 calcein-AM (Molecular Probes, Leiden, the
Netherlands) for 30minutes at 37 1C. A volume of 27 ml of the
chemotactic stimulus or control medium (PBS) was filled in the
bottom chamber of disposable 96-well plates (Neuro Probe) and
covered with a polycarbonate filter with a pore size of 5mm. 1 105
labeled pDCs were loaded in a volume of 25 ml PBS on top of the
membrane. After incubation for 90minutes at 37 1C, remaining cells
on top of the membranes were carefully removed by wiping. Calcein
fluorescence in the bottom chamber was measured using the
FLUOstar Galaxy (BMG Labtechnologies, Offenburg, Germany).
The number of migrated cells equivalent to calcein fluorescence was
calculated from a standard curve with known cell number.
Statistical analysis
Before statistical analysis a normality test was performed, for
calculation of P-values either an unpaired t-test (Figure 1), Wilcoxon
matched pairs test (Figures 3 and 6b), or paired t-test (Figures 4 and
6c) was used; a P-value below 0.05 was regarded as significant.
*Po0.05 and **Po0.005. The program GraphPad Prism version 5
(GraphPad Software, San Diego, CA) was used for statistical analysis.
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